RaySearch Laboratories AB (publ)
RSLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,898,586 | $10,336,243 | $7,740,782 | $7,240,147 |
| - Cash | $322,800 | $402,807 | $503,376 | $462,740 |
| + Debt | $411,100 | $429,981 | $449,437 | $471,934 |
| Enterprise Value | $8,986,886 | $10,363,417 | $7,686,843 | $7,249,341 |
| Revenue | $332,300 | $304,866 | $331,698 | $322,665 |
| % Growth | 9% | -8.1% | 2.8% | – |
| Gross Profit | $320,500 | $276,969 | $305,228 | $297,873 |
| % Margin | 96.4% | 90.8% | 92% | 92.3% |
| EBITDA | $89,100 | $36,362 | $74,826 | $73,579 |
| % Margin | 26.8% | 11.9% | 22.6% | 22.8% |
| Net Income | $71,600 | $30,762 | $56,807 | $59,996 |
| % Margin | 21.5% | 10.1% | 17.1% | 18.6% |
| EPS Diluted | 2.09 | 0.9 | 1.66 | 1.75 |
| % Growth | 132.2% | -45.8% | -5.1% | – |
| Operating Cash Flow | -$11,600 | $70,578 | $146,809 | $102,892 |
| Capital Expenditures | -$51,000 | -$52,746 | -$61,940 | -$60,770 |
| Free Cash Flow | -$62,600 | $17,832 | $84,869 | $42,122 |